Bacteriologically Confirmed Neuromeningeal Tuberculosis at the Hubert Koutoukou Maga National Hospital and University Center in Cotonou: About Two Cases Study and a Review of the Literature
Introduction: Tuberculosis remains a major public health problem. The damage to the central nervous system is severe. We reported here two cases. Clinical Case 1: A 37-year-old female patient, naively Human Immunodeficiency Virus1 (HIV1)-positive with antiretroviral (ARV) treatment, hospitalized in the Internal Medicine department for altered consciousness in a febrile context. The clinical examination at admission noted a meningeal syndrome. Cytological analysis of the cerebrospinal fluid (CSF) revealed lymphocytic meningitis with 98% lymphocytes for 3634 leukocytes. CSF polymerase chain reaction (PCR) detected Mycobacterium tuberculosis DNA. She was put on anti-tuberculosis treatment. The immediate course was favourable, but a secondary worsening of the clinical picture was the cause of his death. Clinical Case 2: A 34-year-old male patient, naively HIV1-positive with ARV treatment. He is hospitalized in the Multi-Purpose Anaesthesia and Resuscitation Department of the CNHU HKM for altered consciousness in a feverish context. The clinical examination noted a meningeal syndrome. The cytological analysis of the CSF noted 184 leukocytes for 99% lymphocytes. The CSF PCR identified the DNA of Mycobacterium tuberculosis. He was put on anti-tuberculosis treatment. The evolution was marked by his death. Conclusion: The neuromeningeal localization of tuberculosis is a poor prognosis. Co-infection with HIV remains a potential deadly combination.
References
[1]
Mazza-Stalder, J., Nicod, L. and Janssens, J.P. (2012) Extrapulmonary Tuberculosis. Respiratory Disease Review, 29, 566-578. https://doi.org/10.1016/j.rmr.2011.05.021
[2]
Dagnra, A.Y., Adjoh, K., Tchaptchet, H.S., Patassi A.A., Sadzo, H.D., Awokou, F., et al. (2011) Prevalence of HIV-Tuberculosis Co-Infection and Impact of HIV Infection on the Evolution of Pulmonary Tuberculosis in Togo. Bulletin de la Société de Pathologie Exotique, 104, 342-346. https://doi.org/10.1007/s13149-010-0079-3
[3]
Cherif, J., Ben Salah, N., Toujani S., Ouahchi, Y., Zakhama, H., Louzir, B., Mehiri-Ben, Rhouma, N. and Beji, M. (2014) Epidemiology of Tuberculosis. Revue de Pneumologie Clinique, 71, 67-72. https://doi.org/10.1016/j.pneumo.2014.04.002
[4]
Horo, K., Touré, K., Brou-Gode, V.-C., AhuB, J.M.I., Kouassi, B.A., Gnazé, A.Z., et al. (2012) Tuberculosis in the Elderly: Epidemiology and Becoming Outpatients in Abidjan. Revue d’épidémiologie et de Santé Publique, 60, 484-488. https://doi.org/10.1016/j.respe.2012.02.009
[5]
Word Health Organisation (2015) Incidence of Tuberculosis per 100,000 People. Global Tuberculosis Report. https://data.worldbank.org/indicator/SH.TBS.INCD?locations=BJ
[6]
Katti, M.K. (2004) Pathogenesis, Diagnosis, Treatment, and Outcome Aspects of Cerebral Tuberculosis. Medical Science Monitor, 10, 215-229.
[7]
Bazin, C. (2004) Tuberculosis of the Central Nervous System. EMC: Neurologie, 1, 169-192.
[8]
Khalid, M., Tarik, B. and Abdelhadi, R. (2017) Tuberculous Meningoencephalitis Revealed by Psychiatric Disorders: About A Case. Pan African Medical Journal, 27, 206.
[9]
Anderson, N.E., Somaratne, J., Mason, D.F., Holland, D. and Thomas, M.G. (2010) A Review of Tuberculous Meningitis at Auckland City Hospital, New Zealand. Journal of Clinical Neuroscience, 17, 1018-1022. https://doi.org/10.1016/j.jocn.2010.01.007
[10]
Dollo, I., Fane, E.M., Es-Sebbani, M., Chakib, A., Sodgi, M., Ouladlahsen, A. et al. (2017) Confirmed Tuberculous Meningitis: About 52 Cases. Pratique Neurologique FMC, 8, 168-173. https://doi.org/10.1016/j.praneu.2017.06.011
[11]
De Seze, J., Deligne, L., Defebvre L., Ferriby, D., Charpentier P., Stojkovic, T., et al. (2004) Neuromeningeal Tuberculosis: Contribution of the Gene Amplification Method to Diagnosis. Revista de Neurología (Paris), 160, 413-418. https://doi.org/10.1016/S0035-3787(04)70922-4
[12]
Miliani, M. (2016) Neuromeningeal Tuberculosis. Retrospective Study of a Series of 16 Cases with Literature Review. M.D. Thesis, Université SIDI Mohammed Ben Abdellah (Faculty of Medicine and Pharmacy), Maroc. N°166/16. 16 p.
[13]
Raveloson, N.E., Rakotoarivony, S.T., Rasamimanana, N.G., Raharimanana, N.R., Andrianjatovo, J.J. and Sztark, F. (2009) About a Case of Meningitis Tuberculosis of Deceptive Form. Journal of Anesthesia-Resuscitation and Emergency Medicine, 1, 11-13.
[14]
Lot, F., Pinget, R., Cazein, F., Pillonel, J., Leclers, M., Haguy, H., et al. (2009) Frequency and Risk Factors of Inaugural AIDS Tuberculosis in France. Bulletin épidémiologique Hebdomadaire, 13, 289-293.
[15]
Cherian, A. and Thomas, S.V. (2011) Central Nervous System Tuberculosis. African Health Sciences, 11, 116-127.
[16]
Thwaites, G.E. and Hien, T.T. (2005) Tuberculous Meningitis: Many Questions, too Few Answers. The Lancet Neurology, 4, 160-170. https://doi.org/10.1016/S1474-4422(05)70019-3
[17]
Thwaites, G.E., Bang, N.D., Dung, N.H., Quy, H.T., Oanh, T.T., Thoa, N.T.C., et al. (2004) Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults. The New England Journal of Medicine, 351, 1741-1751. https://doi.org/10.1056/NEJMoa040573
[18]
The British Medical Research Council (2016) Clinical Stages for Tuberculous Meningitis. http://www.meducator3.net/.../british-medical-research-council-bmrc